While I have a wide range of interests, I am innately interested in neoplasia, particularly solid tumors. My training and experience in molecular pathology is very useful as the field of genomic medicine is honing in on tumor molecular pathogenesis, pathway analysis and targeted therapy. It is an exciting time for research in this field as we have many new tools at our disposal that can assist us in making inroads into handling this major contributor of mortality. I am a member of the department’s Genomic Medicine initiative. I am an active member of the Association for Molecular Pathology (AMP) and as a member of AMP’s Professional Relations Committee, seek to interact with regulatory and governing agencies to explain the intricacies of the practice of molecular pathology and the practice of medicine in order to optimize the conditions of practice of this specialty. I have also participated in the Clinical & Laboratory Standards Institute (CLSI) proceedings and have co-authored two CLSI Guideline publications.
Within the broad field of solid tumors, I have special interest in epithelial (breast, colon) and soft tissue malignancies (sarcomas). I am the pathology representative to the Breast Program Leadership Subcommittee, which successfully achieved NAPBC accreditation in 2016. I am also involved in ongoing research projects to establish mouse xenografts of human breast cancers as well transcriptomic analysis of breast tumors. Similar next generation sequencing projects are also underway in selected sarcomas.
In addition to practicing traditional pathology I also have an interest in evolving and updating the field considering that we have a host of new technologies such as vibrational and infra-red spectroscopy and have ongoing research efforts and publications in these fields.